SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

被引：0
|
作者：
Xie, Z. [1 ]
Ye, L. [1 ]
Hu, W. [2 ]
Lv, C. [3 ]
Zhu, M. [3 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Peoples R China
[2] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[3] Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [42] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
    Venkateshwarlu Kudiganti
    Raveendra Ramamurthy Kodur
    Sushma Raveendra Kodur
    Manjunath Halemane
    Dheeraj Kumar Deep
    Lipids in Health and Disease, 15
  • [43] Reversal of Clopidogrel-Induced Bleeding with rFVIIa in Healthy Subjects: A Randomized, Placebo-Controlled, Double-Blind, Exploratory Study
    Skolnick, Brett E.
    Shenouda, Magdy
    Khutoryansky, Naum M.
    Pusateri, Anthony E.
    Gabriel, Don
    Carr, Marcus E.
    ANESTHESIA AND ANALGESIA, 2011, 113 (04): : 703 - 710
  • [44] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Cheng, Jocelyn Y.
    Moline, Margaret
    Zammit, Gary K.
    Filippov, Gleb
    Bsharat, Mohammad
    Hall, Nancy
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 449 - 457
  • [45] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Jocelyn Y. Cheng
    Margaret Moline
    Gary K. Zammit
    Gleb Filippov
    Mohammad Bsharat
    Nancy Hall
    Clinical Drug Investigation, 2021, 41 : 449 - 457
  • [46] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
    Kudiganti, Venkateshwarlu
    Kodur, Raveendra Ramamurthy
    Kodur, Sushma Raveendra
    Halemane, Manjunath
    Deep, Dheeraj Kumar
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [47] EFFECTS OF CYCLANDELATE ON THE CNS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN YOUNG, HEALTHY-SUBJECTS
    DIMPFEL, W
    NETTER, P
    SPULER, M
    WEDEKIND, W
    KLINISCHE WOCHENSCHRIFT, 1991, 69 (07): : 313 - 319
  • [48] PHARMACOKINETICS OF LACOSAMIDE IN KOREAN HEALTHY SUBJECTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND REPEATED DOSE STUDY.
    Gu, N.
    Kim, B. H.
    Lee, S.
    Kim, T. E.
    Fichtner, A.
    Elshoff, J.
    Yu, K. S.
    King, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S84 - S85
  • [49] Fostamatinib treatment of warm antibody autoimmune hemolytic anemia: a global, randomized, double-blind, placebo-controlled, phase 3 study
    Cooper, Nichola
    Numerof, Robert
    Stacey, Duncan
    Tong, Sandra
    Kuter, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 63 - 63
  • [50] Effects of sucralose on insulin and glucagon-like peptide-1 secretion in healthy subjects: a randomized, double-blind, placebo-controlled trial
    Lertrit, Amornpan
    Srimachai, Sasinee
    Saetung, Sunee
    Chanprasertyothin, Suwannee
    Chailurkit, La-or
    Areevut, Chatvara
    Katekao, Pornalat
    Ongphiphadhanakul, Boonsong
    Sriphrapradang, Chutintorn
    NUTRITION, 2018, 55-56 : 125 - 130
12345